NCT03520218View on ClinicalTrials.gov

Evaluating Positron Emission Mammography Imaging of Suspicious Breast Abnormalities

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 17, 2019

Primary Completion Date

November 3, 2022

Study Completion Date

November 3, 2023

Conditions
Breast Cancer
Interventions
DEVICE

Performance of R-PEM

R-PEM imaging will produce high-sensitivity images with low levels of F-18 FDG and optional subsequent scans performed will display reduced levels of the injected radiotracer.

Trial Locations (1)

M5G 2M9

Princess Margaret Cancer Centre, University Health Network, 610 University Ave., Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT03520218 - Evaluating Positron Emission Mammography Imaging of Suspicious Breast Abnormalities | Biotech Hunter | Biotech Hunter